Welcome to the Hope Bio Blog

By Jan Shultis, Ph.D. Earlier this year, a peer-reviewed piece on an FDA-authorized clinical trial in Parkinson’s Disease was published by Wiley. Currently screening is underway for another Parkinson’s Disease trial, the seventh using Hope Bio’s cells to date, while detailed analysis continues on a completed Phase II trial that announced positive topline results. As we head into the fourth quarter of 2026, let’s take a look at what the Wiley piece says in plain language, wher

The Quest for Optimal Health By the Hope Biosciences Editorial Team You've probably heard of hackers that break into computers and smartphones and steal your personal information, but did you know that there is a new group on the rise that is sweeping up the field of biotechnology? They are known as the "biohackers". Despite its association with the term "hacking", biohacking is not about breaking into systems or stealing information. Instead, it is driven by a community of s